Market revenue in 2023 | USD 1,293.6 million |
Market revenue in 2030 | USD 2,309.3 million |
Growth rate | 8.6% (CAGR from 2023 to 2030) |
Largest segment | Anti-infective |
Fastest growing segment | Endocrinology |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Anti-Infective, Endocrinology, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals |
Key market players worldwide | CVS Group PLC, Walgreens Boots Alliance Inc, UnitedHealth Group Inc, BrightSpring Health Services Inc, Fresenius Medical Care AG, ICU Medical Inc, B. Braun Medical, Baxter International Inc, BD, Smiths Group PLC, Terumo Corp, Caesarea Medical Electronics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to home infusion therapy market will help companies and investors design strategic landscapes.
Anti-infective was the largest segment with a revenue share of 26.76% in 2023. Horizon Databook has segmented the France home infusion therapy market based on anti-infective, endocrinology, hydration therapy, chemotherapy, enteral nutrition, parenteral nutrition, specialty pharmaceuticals covering the revenue growth of each sub-segment from 2018 to 2030.
France is anticipated to witness a substantial growth over the forecast period. According to Cable News Network, France is projected to have a super-aged society by 2030, with nearly 23.2% of its population above 65 years of age. Growing geriatric population is anticipated to boost the demand for healthcare services, especially home and long-term care services. The French government provides about 70% of refund to patients for medical treatment & visits through social security, and 100% in case of long-term ailments, according to expat.com.
Only authorized or agreed home help and care agencies delivering both home help & personal care to frail elderly persons or disabled persons younger than 60 are financed by public money. Long-term care services are provided either in nursing homes with medical services funded by National Sickness Fund or at home by Home Help and Care Agencies (SAD) and/or by nursing agencies.
Social services (home help and personal care) are partially publicly funded through a care attendance allowance called APA . Strong involvement of the French government in delivery of home care and favorable reimbursement scenario for healthcare services are expected to boost the growth of France home infusion therapy market.
Horizon Databook provides a detailed overview of country-level data and insights on the France home infusion therapy market , including forecasts for subscribers. This country databook contains high-level insights into France home infusion therapy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account